Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
| Autor: | le Roux, Carel W, Steen, Oren, Lucas, Kathryn J, Startseva, Elena, Unseld, Anna, Hennige, Anita M * |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology March 2024 12(3):162-173 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|